A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
This study has been completed.
Study NCT00383162
Information provided by GlaxoSmithKline
First Received on September 29, 2006.
Last Updated on May 31, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
